Bortezomib for Injection IP Product Specifications
Cancer Treatment
BORTEZOMIB
10-30 DEG. CELCIUS
ANTI CANCER USE
Injection
2MG,3.5MG
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Liquid
Bortezomib for Injection IP Trade Information
Telegraphic Transfer (T/T)
100 Bottle Per Day
8-10 Days
Australia North America South America Eastern Europe Western Europe Middle East Africa Central America Asia
All India
FDA
Product Description
Bortezomib for Injection (Bortenat Injection) is a medication used in the treatment of certain types of cancer, particularly multiple myeloma and mantle cell lymphoma. It belongs to a class of medications known as proteasome inhibitors. Bortezomib works by interfering with the growth and spread of cancer cells in the body.
This medication is typically administered intravenously (into a vein) by a healthcare professional in a clinic or hospital setting. It may be given alone or in combination with other cancer medications as part of a chemotherapy regimen.
Common side effects of bortezomib may include nausea, diarrhea, constipation, fatigue, peripheral neuropathy (numbness or tingling in the hands and feet), low blood cell counts, and fever. Your healthcare provider will monitor you closely for any potential side effects and adjust your treatment regimen as needed.
Its important to follow your healthcare providers instructions carefully while receiving bortezomib treatment and to report any unusual or severe side effects promptly. Additionally, discuss any concerns or questions you have about this medication with your healthcare provider or pharmacist.
Specifications:
1. Brand: Bortenat
2. Composition: Bortezomib
3. Manufacturer: Natco
4. Treatment: Anti-cancer
5. Packaging Size: 1 Vial
6. Form: Injection
FAQs of Bortezomib for Injection IP:
Q: What is the recommended storage temperature for Bortezomib for Injection IP?
A: The recommended storage temperature for Bortezomib for Injection IP is 10-30 degrees Celsius.
Q: What are the ingredients of Bortezomib for Injection IP?
A: The ingredients of Bortezomib for Injection IP include Bortezomib.
Q: What is the recommended dosage for Bortezomib for Injection IP?
A: The recommended dosage for Bortezomib for Injection IP is 2mg or 3.5mg, as prescribed by your doctor or nurse.
Q: What is the physical form of Bortezomib for Injection IP?
A: The physical form of Bortezomib for Injection IP is a liquid.
Q: What is the function of Bortezomib for Injection IP?
A: Bortezomib for Injection IP is used for cancer treatment as an anti-cancer medication.